NIFTY 50▼25,356.50
-32.40 (-0.13%)
SENSEX▼82,890.94
-71.77 (-0.09%)
NIFTY BANK▲51,938.05
165.65 (0.32%)
TATA MOTORS▲992.10
5.95 (0.60%)
SUZLON ENERGY▲83.11
1.41 (1.73%)
INDIAN RAILWAY FINANCE CORP▲167.25
0.23 (0.14%)
TATA STEEL▲153.49
1.75 (1.15%)
TATA POWER▲441.80
1.90 (0.43%)
RAIL VIKAS NIGAM▲555.30
3.30 (0.60%)
INDIAN RENEWABLE ENERGY▼231.59
-1.05 (-0.45%)
RELIANCE INDUSTRIES▼2,945.25
-14.35 (-0.48%)
VODAFONE IDEA▼13.41
-0.11 (-0.81%)
ZOMATO▼272.90
-11.00 (-3.87%)
ADANI POWER▼633.45
-17.65 (-2.71%)
YES BANK▼23.30
-0.13 (-0.55%)
NHPC▼94.28
-1.02 (-1.07%)
RELIANCE POWER▲29.83
0.16 (0.54%)
STATE BANK OF INDIA▲790.85
3.10 (0.39%)
HDFC BANK▼1,665.95
-0.65 (-0.04%)
JIO FIN SERVICES LTD▲351.90
2.10 (0.60%)
ADANI PORT & SEZ▼1,452.10
-20.50 (-1.39%)
BHARAT ELECTRONICS▼289.95
-1.75 (-0.60%)
GTL INFRA▼2.56
-0.02 (-0.78%)
INDIAN OIL CORP▼173.19
-0.07 (-0.04%)
MRF▲1,37,485.00
1522.75 (1.12%)
OLA ELECTRIC MOBILITY LTD▼111.58
-1.06 (-0.94%)
INDIAN RAILWAY TOURISM CORP▲936.90
5.55 (0.60%)
RATTANINDIA POWER▼15.29
-0.19 (-1.23%)
Concord Biotech Share Price
CONCORDBIO
₹2,079.30+₹74.55 (3.72%) TodayLast updated on 13 Sep, 2024 | 15:45 IST
Please wait...
What’s in news?
Company overview
Financial performance
Market cap
| Open₹2,000.00 | Close₹2,004.75 |
Circuit range₹2,495.15 - ₹1,663.45 | Day range₹1,988.45 - ₹2,138.75 | Year range₹958.70 - ₹2,138.75 |
Volume4,35,094 | Avg. traded₹2,088.93 | Revenue (12m)₹1,038 Crs |
Concord BiotechConcord Biotech Limited is an India-based research and development driven biopharma company. The Company is engaged in the research and development, manufacturing, marketing, and selling of pharmaceutical products. The Company manufactures active pharmaceutical ingredients (API) through fermentation and semi-synthetic process and finished formulations. The Company’s offerings span both bio-pharmaceutical APIs and formulations across therapeutic areas like immunosuppressants oncology, anti-infectives nephrology, and critical care. Its portfolio also includes fermentation-based APIs in anti-bacterial, anti-fungal, and other therapeutic segments. Its API products include Mycophenolate Mofetil, Mycophenolate Sodium, Cyclosporine, Sirolimus, Pimecrolimus, Voclosporin, Mupirocin, Mupirocin Calcium, Vancomycin Hydrochloride, Teicoplanin, Polymyxin B Sulfate, Fidaxomicin, Anidulafungin. Its API products under development include Daptomycin, Epirubicin, Idarubicin, and Pirarubicin.
Concord Biotech Key indicators
52 week high₹2,138.75 | 52 week low₹958.70 | P/E ratio64.85 |
P/B ratio12.81 | ROE21.63% | ROCE28.89% |
Dividend yield0.48% | Debt/Equity ratio | EPS29.13 |
Learn more
Featured in
Investment checklist: (3/6)
Equity returns
Dividend returns
Safety factor
Growth factor
Debt vs Equity
Profit factor
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily
Analyst ratings:
Analyst ratings:
67%
Hold
33%
Sell
0%
This analysis is based on the reviews of 3 experts in the last 7 days
Fundamentals
Financial ratios
Operating profit margin45.82% | Net profit margin29.97% |
ROE21.63% | ROA18.96% |
ROCE28.89% |
Learn more
Concord Biotech Share Price history
Day | Open | Close | Day’s change |
---|---|---|---|
Fri, Sep 13 2024 | ₹2,000.00 | ₹2,079.30 | |
Thu, Sep 12 2024 | ₹1,956.95 | ₹2,004.75 | |
Wed, Sep 11 2024 | ₹1,897.65 | ₹1,941.00 | |
Tue, Sep 10 2024 | ₹1,860.00 | ₹1,897.65 | |
Mon, Sep 9 2024 | ₹1,829.95 | ₹1,854.40 | |
Fri, Sep 6 2024 | ₹1,864.00 | ₹1,835.90 | -0.96% |
Thu, Sep 5 2024 | ₹1,800.00 | ₹1,853.70 | |
Wed, Sep 4 2024 | ₹1,746.70 | ₹1,787.45 |
Events
Corporate actions
Dividend • ₹8.75/share
Ex date 21 Jun 2024
Learn more